Development of a novel PRO instrument for use in familial chylomicronemia syndrome.
David DavidsonChristina SlotaMontserrat Vera-LlonchT Michelle BrownAndrew HsiehSheri E FehnelPublished in: Journal of patient-reported outcomes (2021)
The content validity of the final 17-item FCS Symptoms and Impacts Scale is strongly supported by patient input gathered through both a large burden-of-illness study and qualitative research. To further support use in clinical trials, psychometric evaluation of the measure is underway.